CoChat

Clinical Characteristics and Survival in Systemic Sclerosis-Related Pulmonary Hypertension Associated With Interstitial Lung Disease

The DOI matches its Crossref record; 39 of the 39 references it cites were found in a registry or an index.

Abstract

Background Pulmonary hypertension (PH) complicating systemic sclerosis (SSc)-related interstitial lung disease (ILD) is usually associated with a poor prognosis. However, data are either lacking or scarce on prognostic factors in this condition. The objectives of this study were to compare the survival of patients with ILD-associated PH (PH-ILD) or pulmonary arterial hypertension (PAH) and to determine whether the severity of PH has prognostic value in SSc-associated PH-ILD.Methods Consecutive patients with SSc and PH-ILD (n = 47) or PAH (n = 50) confirmed by right-sided heart catheterization were included in a cross-sectional analysis. PH was classified as mild (mean pulmonary arterial pressure [mPAP] ≤ 35 mm Hg) or moderate to severe (mPAP > 35 mm Hg).Results As compared with patients with PAH, subjects with PH-ILD were younger, were more frequently men with a history of smoking, had more frequently diffuse SSc, less frequently anticentromere antibodies, and a lower FVC/diffusing capacity of lung for carbon monoxide (DLCO) ratio. They had a worse prognosis than patients with PAH (3-year survival of 47% vs 71%, respectively; P = .07). Patients with mild PH-ILD had similar poor outcomes when compared with those with moderate to severe PH-ILD. Pericardial effusion (hazard ratio [HR], 2.44; P = .04) and lower DLCO (HR, 0.96; P = .01) were the only independent factors predictive of a poor survival in the PH-ILD group.Conclusions Patients with SSc with PH-ILD had a different phenotype and a worse prognosis than those with SSc and PAH. Lower DLCO and presence of pericardial effusion were predictive of a poor outcome in PH-ILD, whereas mPAP seemed to have no prognostic significance.

Overview

Integrity signals

Registry

Crossref · 10.1378/chest.10-2473

Cites

39 of 39 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 39 references

Cited by

See all 99

Metadata

Authors
Launay, D., Humbert, M., Berezne, A., Cottin, V., Allanore, Y., Couderc, L.-J., Bletry, O., Yaici, A., Hatron, P.-Y., Mouthon, L., Le Pavec, J., Clerson, P., & Hachulla, E.
Affiliations
  • Université de Lille (FR)
  • Université Paris-Sud (FR)
  • Hôpital Cochin (FR)
  • Lyon 1 Université (FR)
  • Hôpital Foch (FR)
Corresponding author
Launay, David
Venue
Chest
Publisher
Elsevier BV
Published
2011-10
Volume
140
Issue
4
Pages
1016-1024
ISSN
0012-3692 (ISSN-L)
OpenAlex
W2130932769
Cited by
99
References
39
Citations by year
2026: 2 · 2025: 2 · 2024: 5 · 2023: 6 · 2022: 3 · 2021: 7 · 2020: 5 · 2019: 5 · 2018: 7 · 2017: 7 · 2016: 7 · 2015: 8 · 2014: 11 · 2013: 15 · 2012: 5
FWCI
9.52
Type
journal article
Language
en
Open access
closed
Licence
  • www.elsevier.com/tdm/userlicense/1.0/ (tdm)
  • www.elsevier.com/legal/tdmrep-license (tdm)
Locations
  • CHEST Journal (publishedVersion)
  • PubMed (publishedVersion)
  • HAL (submittedVersion)
Topics
  • Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Pulmonary Hypertension Research and Treatments
  • Health Sciences › Medicine › Rheumatology › Systemic Sclerosis and Related Diseases
  • Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
Keywords
systemic sclerosis, pulmonary hypertension, interstitial lung disease, pulmonary arterial hypertension, survival, prognostic factors, pericardial effusion, diffusing capacity for carbon monoxide, mean pulmonary artery pressure, right heart catheterization
MeSH terms
Adult, Aged, Antibodies, Antinuclear, Blood Pressure, Carbon Monoxide, Cross-Sectional Studies, Female, Humans, Hypertension, Pulmonary, Lung, Male, Middle Aged, Predictive Value of Tests, Prognosis, Scleroderma, Systemic, Severity of Illness Index, Comorbidity, Survival Rate, Lung Diseases, Interstitial, Familial Primary Pulmonary Hypertension

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Clinical Characteristics and Survival in Systemic Sclerosis-Related Pulmonary Hypertension Associated With Interstitial Lung Disease. https://app.cochat.ai/papers/10.1378/chest.10-2473
The paper
Launay, D., Humbert, M., Berezne, A., Cottin, V., Allanore, Y., Couderc, L.-J., Bletry, O., Yaici, A., Hatron, P.-Y., Mouthon, L., Le Pavec, J., Clerson, P., & Hachulla, E. (2011). Clinical Characteristics and Survival in Systemic Sclerosis-Related Pulmonary Hypertension Associated With Interstitial Lung Disease. Chest. https://doi.org/10.1378/chest.10-2473

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.